Monthly
US$200
Billed every month
Sign in to subscribeApplication numbers, product numbers and original fields are retained. Marketing status is shown as listed in the source.
Currently marketed products: 12 · Counts FDA prescription and OTC marketing categories as listed; discontinued or unknown categories are excluded.
| Application / product number | Brand name (original) | Applicant (original) | Dosage form (original) | Route (original) | Strength (original) | Earliest approval | RLD / RS | Marketing status (original) | Official source |
|---|---|---|---|---|---|---|---|---|---|
| A201211-001 | BROMFENAC SODIUM | COASTAL PHARMACEUTICALS | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.09% ACID | 2011/05/11 | N / N | DISCONTINUED | openFDA ↗ |
| A201941-001 | BROMFENAC SODIUM | CHARTWELL RX SCIENCES LLC | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.09% ACID | 2015/02/10 | N / N | DISCONTINUED | openFDA ↗ |
| A202030-001 | BROMFENAC SODIUM | J MOLNER HOLDINGS INC | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.09% ACID | 2013/01/09 | N / N | DISCONTINUED | openFDA ↗ |
| A202435-001 | BROMFENAC SODIUM | APOTEX INC | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.09% ACID | 2014/06/19 | N / N | DISCONTINUED | openFDA ↗ |
| A202620-001 | BROMFENAC SODIUM | APOTEX INC | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.09% ACID | 2014/06/23 | N / N | DISCONTINUED | openFDA ↗ |
| A202903-001 | BROMFENAC SODIUM | LUPIN LTD | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.09% ACID | 2023/08/15 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A203368-001 | BROMFENAC SODIUM | RISING PHARMA HOLDING INC | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.09% ACID | 2019/06/03 | N / N | DISCONTINUED | openFDA ↗ |
| A203395-001 | BROMFENAC SODIUM | SENTISS AG | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.09% ACID | 2014/01/22 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204813-001 | BROMFENAC SODIUM | EUGIA PHARMA SPECIALITIES LTD | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.09% ACID | 2022/03/18 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206027-001 | BROMFENAC SODIUM | LUPIN LTD | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.07% ACID | 2023/11/22 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207334-001 | BROMFENAC SODIUM | APOTEX INC | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.07% ACID | 2024/07/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210560-001 | BROMFENAC SODIUM | ALEMBIC PHARMACEUTICALS LTD | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.09% ACID | 2019/06/21 | N / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210962-001 | BROMFENAC SODIUM | AMNEAL EU LTD | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.07% ACID | 2024/07/29 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211029-001 | BROMFENAC SODIUM | GLAND PHARMA LTD | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.09% ACID | 2020/03/17 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211239-001 | BROMFENAC SODIUM | LUPIN LTD | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.075% ACID | 2024/02/02 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A214340-001 | BROMFENAC SODIUM | ALEMBIC PHARMACEUTICALS LTD | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.07% ACID | 2024/07/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N021664-001 | XIBROM | BAUSCH AND LOMB INC | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.09% ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2005/03/24 | Y / N | DISCONTINUED | openFDA ↗ |
| N021664-002 | BROMDAY | BAUSCH AND LOMB INC | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.09% ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2010/10/16 | Y / N | DISCONTINUED | openFDA ↗ |
| N203168-001 | PROLENSA | BAUSCH AND LOMB INC | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.07% ACID | 2013/04/05 | Y / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N206911-001 | BROMSITE | SUN PHARMACEUTICAL INDUSTRIES LTD | SOLUTION/DROPS | OPHTHALMIC | BROMFENAC SODIUM: EQ 0.075% ACID | 2016/04/08 | Y / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
*PED rows, substance/product flags, use codes and delisting-request flags are retained without determining legal effect.
This column includes only source rows explicitly flagged DS. A PED row without that flag is not assigned one by this site.
| Application / product number | Patent number | Listed expiration | Substance / product flags | Use code | Delisting request | Official source |
|---|---|---|---|---|---|---|
| N203168-001 | 10085958 | 2032/11/19 | — / Y | — | — | openFDA ↗ |
| N203168-001 | 9517220 | 2033/11/11 | — / — | U-1933 | — | openFDA ↗ |
| N206911-001 | RE50218 | 2029/03/05 | — / Y | U-1834 | — | openFDA ↗ |
Latest exclusivity expiration: —
| Application / product number | Exclusivity code | Listed expiration | Official source |
|---|---|---|---|
| Not listed | |||
The four-zero filter applies only to matched rows: catalog holders, NHSA approval numbers, applications under review, and companies filing generics this year. Unmatched rows have no Chinese counts. Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| SENJU PHARMACEUTICAL CO., LTD. | H20150243See source | 2009/09/29 | Official source ↗ |
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Guangdong Zhong Sheng Pharma Co., Ltd. romanized | 国药准字H20233262See source | — | Official source ↗ |
| Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanized | 国药准字H20213053See source | — | Official source ↗ |
| Shenyang Xing Qi Yan Yao Co., Ltd. romanized | 国药准字H20244468See source | — | Official source ↗ |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20234193See source | — | Official source ↗ |
| Wuhan Wu Jing Pharma Co., Ltd. romanized | 国药准字H20244284See source | — | Official source ↗ |
| Chengdu Pusch Pharmaceutical Co., Ltd. | 国药准字H20256506See source | — | Official source ↗ |
| Qilu Pharmaceutical Co., Ltd. | 国药准字H20183490See source | — | Official source ↗ |
| Jinan Chen Xin Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H201500225ml:5mg(0.1%) | — | Official source ↗ |
| Hefei Hua Wei Pharma Co., Ltd. romanized | 国药准字H20244569See source | — | Official source ↗ |
| Zhejiang Sha Pu Ai Si Pharma Co., Ltd. romanized | 国药准字H20253221See source | — | Official source ↗ |
| Jiangxi Ma Ying Long Mei Kang Pharma Co., Ltd. romanized | 国药准字H20264422See source | — | Official source ↗ |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20233640See source | — | Official source ↗ |
| Liaoning Mei Zi Lin Pharma Co., Ltd. romanized | 国药准字H20193244See source | — | Official source ↗ |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20243868See source | — | Official source ↗ |
| Hebei Chuang Jian Pharma Co., Ltd. romanized | 国药准字H20243677See source | — | Official source ↗ |
| SENJU PHARMACEUTICAL CO.,LTD. | 国药准字HJ20150243See source | — | Official source ↗ |
| Wuhan Xian Lu Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20213554See source | — | Official source ↗ |
| Suzhou Ou Kang Wei Shi Bio Technology Co., Ltd. romanized | 国药准字H20253042See source | — | Official source ↗ |
| Guangzhou Ren Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255727See source | — | Official source ↗ |
| Wuhan Xian Lu Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20247205See source | — | Official source ↗ |
| Chengdu Pusch Pharmaceutical Co., Ltd. | 国药准字H20256506See source | — | Official source ↗ |
| Qilu Pharmaceutical Co., Ltd. | 国药准字H20183490See source | — | Official source ↗ |
| Jinan Chen Xin Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H201500225ml:5mg(0.1%) | — | Official source ↗ |
| Guangzhou Ren Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255727See source | — | Official source ↗ |
| Wuhan Xian Lu Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20247205See source | — | Official source ↗ |
| Run Er Yan Ke Drug (Guangzhou) Co., Ltd. romanized | 国药准字H20244161See source | — | Official source ↗ |
| Chengdu Pusch Pharmaceutical Co., Ltd. | 国药准字H20256506See source | — | Official source ↗ |
| Jinan Chen Xin Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H201500225ml:5mg(0.1%) | — | Official source ↗ |
| Guangzhou Ren Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255727See source | — | Official source ↗ |
| Wuhan Xian Lu Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20247205See source | — | Official source ↗ |
| Chengdu Pusch Pharmaceutical Co., Ltd. | 国药准字H20256506See source | — | Official source ↗ |
| Jinan Chen Xin Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H201500225ml:5mg(0.1%) | — | Official source ↗ |
| Guangzhou Ren Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255727See source | — | Official source ↗ |
| Wuhan Xian Lu Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20247205See source | — | Official source ↗ |
| Guangzhou Ren Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255727See source | — | Official source ↗ |
| Wuhan Xian Lu Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20247205See source | — | Official source ↗ |
| Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanized | 国药准字H20223699See source | — | Official source ↗ |
| Qilu Pharmaceutical Co., Ltd. | 国药准字H20183491See source | — | Official source ↗ |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20233366See source | — | Official source ↗ |
| Zhejiang Sha Pu Ai Si Pharma Co., Ltd. romanized | 国药准字H20253220See source | — | Official source ↗ |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20243922See source | — | Official source ↗ |
| Suzhou Ou Kang Wei Shi Bio Technology Co., Ltd. romanized | 国药准字H20263589See source | — | Official source ↗ |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20233366See source | — | Official source ↗ |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20233366See source | — | Official source ↗ |
| Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanized | 国药准字H20233366See source | — | Official source ↗ |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20243868See source | — | Official source ↗ |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20243868See source | — | Official source ↗ |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20243868See source | — | Official source ↗ |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20243868See source | — | Official source ↗ |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20243868See source | — | Official source ↗ |
| Ai Shi Pharmaceutical Co., Ltd. romanized | 国药准字H20264661See source | — | Official source ↗ |
| Ai Shi Pharmaceutical Co., Ltd. romanized | 国药准字H20264662See source | — | Official source ↗ |
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Jiangsu Yuan Heng Pharma Co., Ltd. romanized | CYHS2602322 | 2026/09/17 | Official source ↗ |
| Shandong Hai Shan Pharma Co., Ltd. romanized; Shandong Wei Zhi Bai Ke Pharma Co., Ltd. romanized | CYHS2602111 | 2026/08/25 | Official source ↗ |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CYHS2601517 | 2026/06/26 | Official source ↗ |
| Guangdong Nan Guo Pharma Co., Ltd. romanized | CYHS2601081 | 2026/05/12 | Official source ↗ |
| Shijiazhuang Gree Pharmaceutical Co., Ltd | CYHS2504444 | 2025/12/27 | Official source ↗ |
| Shijiazhuang Gree Pharmaceutical Co., Ltd | CYHS2504443 | 2025/12/27 | Official source ↗ |
| Hubei Mei Lin Pharma Co., Ltd. romanized | CYHS2503161 | 2025/08/29 | Official source ↗ |
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Jiangsu Yuan Heng Pharma Co., Ltd. romanized | CYHS2602322 | 2026/09/17 | Official source ↗ |
| Shandong Hai Shan Pharma Co., Ltd. romanized; Shandong Wei Zhi Bai Ke Pharma Co., Ltd. romanized | CYHS2602111 | 2026/08/25 | Official source ↗ |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CYHS2601517 | 2026/06/26 | Official source ↗ |
| Guangdong Nan Guo Pharma Co., Ltd. romanized | CYHS2601081 | 2026/05/12 | Official source ↗ |
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Shijiazhuang Gree Pharmaceutical Co., Ltd | Y20250000320 | 2026/10/12 | Official source ↗ |
| Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | Y20240000502 | 2025/12/17 | Official source ↗ |
| Medilux Laboratories Pvt. Ltd | Y20230000372 | 2026/07/12 | Official source ↗ |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | Y20220000433 | 2024/03/11 | Official source ↗ |
| Hebei An Jian Cheng Yi Pharmaceuticals Technology Co., Ltd. romanized | Y20210000778 | 2024/04/09 | Official source ↗ |
| Guangzhou Hua Sheng Pharmaceutical Co., Ltd. romanized | Y20210000006 | 2025/04/16 | Official source ↗ |
| Guangdong Xian Qiang Pharma Co., Ltd. romanized | Y20200001049 | 2025/03/27 | Official source ↗ |
| YS Life Science Co., Ltd. | Y20190021249 | 2024/07/27 | Official source ↗ |
| Wuhan Xian Lu Pharmaceuticals Technology Co., Ltd. romanized | Y20190000875 | 2026/06/02 | Official source ↗ |
| Shandong Chen Long Pharma Co., Ltd. romanized | Y20190001971 | 2024/09/27 | Official source ↗ |
| Jin Yao Pharma Co., Ltd. romanized | Y20170002121 | 2025/06/12 | Official source ↗ |
| Indoco Remedies Ltd. (Kilo Lab) | Y20170001316 | 2026/05/06 | Official source ↗ |
| Qilu Pharmaceutical Co., Ltd. | Y20170000569 | 2024/09/04 | Official source ↗ |
| Liaoning Tian Long Pharma Co., Ltd. romanized | Y20170000249 | 2024/09/12 | Official source ↗ |
Not loaded
Chinese counts use complete ingredient, dosage-form and route matches. Unmatched and partial rows show name-source matching only and make no finding about Chinese approvals or filings. Trials cover registration-number years 2025/2026 only.
Comparison generated: 2026/11/13 18:41 · openFDA Orange Book ↗
Subscriptions
US$200
Billed every month
Sign in to subscribeUS$540
Billed every three months
US$180 per month
Sign in to subscribeUS$1,920
Billed every year
US$160 per month
Sign in to subscribeSeparate one-time purchase
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy